Clinical Report: Concurrent Ocular and Dermatologic Toxicities Associated With Docetaxel Chemotherapy
Background
Docetaxel is a chemotherapeutic agent commonly used in the treatment of various cancers, including breast and esophageal cancers. Understanding the potential ocular and dermatologic toxicities associated with docetaxel is crucial for managing patient care and minimizing complications during treatment.
Data Highlights
No numerical data or trial data was provided in the source material.
Key Findings
- Case 1 involved a 64-year-old man who developed ocular toxicity and facial rash after docetaxel treatment, leading to a diagnosis of ulcerative blepharitis.
- Case 2 featured a 50-year-old woman who experienced severe mucositis and a desquamating rash, with significant ocular involvement after her second dose of docetaxel.
- Both patients required modifications to their chemotherapy regimens due to the adverse effects experienced.
- Topical treatments, including corticosteroids and artificial tears, were utilized to manage ocular symptoms.
- Early ophthalmology consultation was emphasized for effective management of ocular toxicities.
Clinical Implications
Healthcare professionals should be vigilant in monitoring for ocular and dermatologic toxicities in patients receiving docetaxel.
Conclusion
The case studies illustrate the importance of recognizing and managing the ocular and dermatologic toxicities associated with docetaxel chemotherapy.
Related Resources & Content
- Contact Lens Spectrum, July 2021 -- TOUCHING THE SURFACE WITH ANTICANCER DRUGS
- The ASCO Post, June 2023 -- Chemotherapy-Induced Peripheral Neuropathy May Be More Severe With Paclitaxel Than With Docetaxel
- The ASCO Post, April 25, 2025 -- Managing Dermatologic Reactions to Combination Therapy for Patients With EGFR-Mutated NSCLC
- Epiphora and Canalicular Stenosis Associated With Adjuvant Docetaxel in Early Breast Cancer: Is Excessive Tearing Clinically Important? | Journal of Clinical Oncology
- Retinal Physician — Retinal Toxicity of Immunotherapy Drugs
- Epiphora and Canalicular Stenosis Associated With Adjuvant Docetaxel in Early Breast Cancer: Is Excessive Tearing Clinically Important? | Journal of Clinical Oncology
- Nail toxicity associated with anticancer agents - PubMed
- FLOT Improves Survival in Locally Advanced Esophageal Cancer - NCI
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
